Already have an ACS ID? Log in
Renew your membership, and continue to enjoy these benefits.
Already an ACS Member? Log in here
Choose the membership that is right for you. Discounts will be applied automatically at checkout.
Enjoy these benefits no matter which membership you pick.
Most Popular in Business
Novo Nordisk will sublease a stem cell therapies development facility in Fremont, Calif., from Asterias Biotherapeutics at which it plans to develop treatments for type 1 diabetes and other diseases. The company hopes to be in operation next year. The deal follows Novo Nordisk’s announcement in May of a deal to license technology from the University of California, San Francisco, for creating human embryonic stem cells for regenerative medicines. Novo Nordisk recently established stem cell R&D operations in Måløv, Denmark.
This article has been sent to the following recipient: